|
15 Aug 2007 |
Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
|
|
15 Aug 2007 |
Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
|
|
15 Aug 2007 |
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
|
|
15 Aug 2007 |
Urigen Pharmaceuticals, Inc. Initiates URG101-104 Phase II Pharmacodynamic Clinical Trial for Painful Bladder Syndrome/Interstitial Cystitis
|
|
15 Aug 2007 |
Phase II clinical trial results for ADENTRI published in “Journal of the American College of Cardiologyâ€
|
|
15 Aug 2007 |
Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders
|
|
15 Aug 2007 |
Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
|
|
15 Aug 2007 |
NeurAxon Announces Positive Phase 1 Trial Data on NXN-188 for Migraine
|
|
15 Aug 2007 |
CombinatoRx announces initiation of phase 2a proof-of-concept clinical study with CRx-401 for Type 2 diabetes
|
|
15 Aug 2007 |
Cytokinetics announces the initiation of a phase I clinical trial for GSK-923295
|
|
15 Aug 2007 |
GlaxoSmithKline updates prescribing information for Avandia in the US
|
|
14 Aug 2007 |
Cipher provides CIP-ISOTRETINOIN regulatory update
|
|
14 Aug 2007 |
Avigen Initiates U.S. Clinical Development for AV411
|
|
12 Aug 2007 |
LifeCycle Pharma and Sciele Pharma announce FDA approval of new formulation of Fenofibrate in 120 mg. and 40 mg. dosage strengths
|
|
11 Aug 2007 |
Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. announce receipt of an FDA action letter for bifeprunox, an investigational treatment for schizophrenia
|
|
11 Aug 2007 |
TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
|
|
11 Aug 2007 |
Potential safety issue identified in ongoing phase 2 clinical study of HCV-796
|
|
11 Aug 2007 |
UK High Court ruled NICE Guidence for Alzheimer's disease discriminatory
|
|
11 Aug 2007 |
FDA approves IND for phase II studies of TASQ
|
|
10 Aug 2007 |
Biovail enters into license and development agreement
|
|
10 Aug 2007 |
GSK receives decision from FDA on Advair 500/50 for COPD
|
|
10 Aug 2007 |
DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
|
|
10 Aug 2007 |
Sirtris Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of SRT501 in MELAS
|
|
10 Aug 2007 |
Spectrum Pharmaceuticals Investigational New Drug Application for SPI-1620 Cleared by U.S. Food & Drug Administration
|
|
10 Aug 2007 |
Phase I intravenous trial for anti-cancer drug achieves primary objectives
|
